Biocon Biologics Ltd
Biocon Biologics Ltd.AliasBiocon BiologicsAlias
Ticker
—
Listed market
—
Country
Employees (non-consolidated)
—
Related companies
0
§01
Basic information
- Head office
- Bengaluru, India
- Chief executive
- Shreehas Tambe
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2004-01-01
- End date
§02
Websites
§03
Business
bUstekinumab, Bmab 1200biosimilar medicinesbiosimilarsOgivri® & Hertraz® (bTrastuzumab)Abevmy® (bBevacizumab)Fulphila® (bPegfilgrastim)Hulio® (bAdalimumab)Nepexto® (bEtanercept)Semglee® (bGlargine)Kirsty® (bAspart)development, manufacturing, distribution and commercialization of biosimilarsInsulin GlargineInsulin Aspartrecombinant Human InsulinTrastuzumabBevacizumabPegfilgrastimAdalimumabEtanerceptbTrastuzumabbPegfilgrastimbAdalimumabAspartbiosimilar assets
§04
Related companies
—
§05
Network
Drag to move · click to open
§06
History
Founded to improve access to quality bioenzymes
Evolves into biopharmaceuticals
Biocon develops human insulin on Pichia
Partners with Mylan/Viatris
Solidifies presence in Europe and global biosimilars space
Continues partnership with Viatris after Mylan/Upjohn merger
Biocon Biologics acquires Viatris’ global biosimilars business to become a fully integrated biosimilars company in the US and Europe
§07
News
There is no news.
§09
Sources & updates
DOMAINOwn domain：Yes
UPDATED2026-11-09 09:12 · Model: gpt-oss-20b(16)